Dr. Gary S. Shifrin, MD

Dr. Shifrin practices at Mount Sinai Heart NY Palm Beach in Jupiter, Florida.

Dr. Shifrin's NPI, 1437257292, was assigned on September 20, 2006. Dr. Shifrin graduated from SUNY Downstate Health Sciences University in 1983. Dr. Shifrin holds Florida license ME53556.

Dr. Shifrin's primary practice is Mount Sinai Heart NY Palm Beach, at 600 University Blvd, Jupiter, FL 33458 in Palm Beach County. The practice phone is (561) 627-2601.

Dr. Shifrin's primary practice is Mount Sinai Heart NY Palm Beach in Jupiter, Florida. Dr. Shifrin is also affiliated with Jupiter Medical Center. The medical group on file is Mount Sinai Heart New York-Palm Beach. Dmand AI also links Dr. Shifrin to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shifrin practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Shifrin's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Shifrin is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Shifrin is licensed in Florida.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, chronic hypertension, chronic skin ulcer, coronary artery disease and heart blockage among the conditions Dr. Shifrin treats.

CMS data shows 3,364 Medicare services from Dr. Shifrin across 18 procedure codes in 2024, for 999 Medicare patients. Medicare paid $219,035 for them.

CMS counts 999 Medicare patients who saw Dr. Shifrin in 2024. The largest group is 75 to 84, with 431 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Shifrin's median patient age at 72, with 45% women.

In 2024, Dr. Shifrin wrote 4,218 Medicare Part D claims for 778 patients. 83% of them were for generic drugs. CMS names the drug for 3,969 of them, across 48 drugs with 11 or more claims each, at $705,765 in total drug cost. In 2023, CMS named 3,408 claims across 42 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Shifrin for performance year 2024, reported as part of a group. Dr. Shifrin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Shifrin.

CMS Open Payments shows 21 general payments to Dr. Shifrin from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $298.

Dmand AI lists 3 awards for Dr. Shifrin, most recently CMS Stage 1 EHR in 2012.

Dr. Shifrin graduated from SUNY Downstate Health Sciences University in 1983. Dr. Shifrin is a member of ACC and ACP.

Dr. Shifrin is in network with 13 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.